Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM <Emphasis Type="Bold">×</Emphasis> anti-CD3): a phase I study 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM <Emphasis Type="Bold">×</Emphasis> anti-CD3): a phase I study

引用本文：	Sebastian M,Passlick B,Friccius-Quecke H,J?ger M,Lindhofer H,Kanniess F,Wiewrodt R,Thiel E,Buhl R,Schmittel A.Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM?×?anti-CD3): a phase I study[J].Cancer Immunology, Immunotherapy,2007,56(10):1637-1644.

作者姓名：	Sebastian M Passlick B Friccius-Quecke H Jäger M Lindhofer H Kanniess F Wiewrodt R Thiel E Buhl R Schmittel A

摘要：
收稿时间：	27 December 2006
修稿时间：	27 February 2007
本文献已被 PubMed SpringerLink 等数据库收录！